Research group - Volkan Özenci
Volkan’s group focuses on improving laboratory diagnostics, and understanding infectious disease epidemiology.
Despite advances in medical science, infectious diseases remain one of the leading causes of morbidity and mortality worldwide. In the light of rapidly evolving pathogens, there is an urgent need for efficient infectious disease diagnosis.
The focus of our research is to improve the current state of clinical microbiology through the evaluation of analytical and clinical performance of new microbiological diagnostic methods, and development of clinical microbiology methods for rapid detection, identification, and antibiotic susceptibility testing of clinically relevant microbes. We also study the epidemiology of severe infectious diseases, as well as bacteria-fungi interactions as we believe that increased understanding of these areas is instrumental in driving improvements to the infection diagnostics landscape. Our lab employs a unique multidisciplinary approach in our research. Volkan’s group has led several clinical studies in collaboration with other centers and the industry. In recent years, our group has published a number of significant studies on novel diagnostic tools for infectious diseases.
Research group leader
Vinnova, Medtech4Health, 2019
- “Clinical Microbiology” course for medical students
- “Applied clinical microbiology in invasive infectious diseases” elective course for medical students
Undergraduate/ graduate: medial students, dental students, nursing students, biomedical analysts students
Clinical supervision of interns/residents: medical doctors, microbiologists, biomedical laboratory scientists
Estimated burden of fungal infections in Sweden.
Özenci V, Klingspor L, Ullberg M, Chryssanthou E, Denning DW, Kondori N
Mycoses 2019 Aug;():
Detailed Analysis of the Characteristics of Sample Volume in Blood Culture Bottles.
Henning C, Aygül N, Dinnétz P, Wallgren K, Özenci V
J. Clin. Microbiol. 2019 Aug;57(8):
Coexistence of Candida species and bacteria in patients with cystic fibrosis.
Haiko J, Saeedi B, Bagger G, Karpati F, Özenci V
Eur. J. Clin. Microbiol. Infect. Dis. 2019 Jun;38(6):1071-1077
Individualized Approaches Are Needed for Optimized Blood Cultures.
Banerjee R, Özenci V, Patel R
Clin. Infect. Dis. 2016 Nov;63(10):1332-1339
Demise of Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry as an Infectious Diseases Diagnostic Tool.
Özenci V, Patel R, Ullberg M, Strålin K
Clin. Infect. Dis. 2018 01;66(3):452-455